Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INNV > SEC Filings for INNV > Form 8-K/A on 10-Mar-2014All Recent SEC Filings

Show all filings for INNOVUS PHARMACEUTICALS, INC.

Form 8-K/A for INNOVUS PHARMACEUTICALS, INC.


10-Mar-2014

Financial Statements and Exhibits


Item 9.01. Financial Statements and Exhibits.

(a) Financial Statements of Business Acquired.

The audited balance sheets of Semprae Laboratories, Inc. as of December 31, 2012 and 2011, and the related statements of operations, changes in redeemable convertible preferred stock and stockholders' deficit and cash flows for the years ended December 31, 2012 and 2011, and the related notes to the financial statements are attached as Exhibit 99.2 to this Form 8-K/A. The unaudited financial statements of Semprae Laboratories, Inc. at September 30, 2013 are attached as Exhibit 99.3 to this Form 8-K/A .

The consent of Ernst & Young LLP, the independent auditors of Semprae Laboratories, is attached as Exhibit 23.1 to this Current Report on Form 8-K/A.

(b) Pro Forma Financial Information.

The following unaudited pro forma combined condensed consolidated financial information related to the Company's acquisition of Semprae Laboratories is attached as Exhibit 99.1 to this Form 8-K/A.

(i) Pro Forma Combined Condensed Statement of Operations (Unaudited) for the year ended December 31, 2012;

(ii) Pro Forma Combined Condensed Statement of Operations (Unaudited) for the nine months ended September 30, 2013; and

(iii) Pro Forma Combined Condensed Balance Sheet (Unaudited) at September 30, 2013.

(d) Exhibits.

Exhibit No.   Description
   23.1       Consent of Ernst & Young, Independent Auditors.

   99.1       Unaudited pro forma combined condensed consolidated financial
              information of Innovus Pharmaceuticals, Inc. and its subsidiaries.

   99.2       The audited balance sheets of Semprae Laboratories, Inc. as of December
              31, 2012 and 2011, and the related statements of operations, changes in
              redeemable convertible preferred stock and stockholders' deficit and
              cash flows for the years ended December 31, 2012 and 2011, and the
              related notes to the financial statements.

   99.3       The unaudited interim financial statements of Semprae Laboratories,
              Inc. at September 30, 2013 and the audited balance sheet at December
              31, 2012, and the related unaudited interim financial statements of
              operations, and cash flows for the nine months ended September 30,
              2013, the unaudited statement of cash flows for the nine months ended
              September 30, 2012, and the audited statements of operations at
              December 31, 2012, and the related notes.

  Add INNV to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INNV - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.